{"schema_version":"secwatch.filing_event.v1","accession":"0001846253-23-000117","form_type":"8-K","ticker":"OABI","cik":"0001846253","company_name":"OmniAb, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.007428+00:00","generated_at":"2026-06-08T07:39:37.846578+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"OmniAb Q3 revenue falls 20% to $5.5M; net loss widens to $15.7M","bullets":["Q3 2023 revenue $5.5M (down 20% YoY); net loss $15.7M ($0.16/share) vs $12.6M loss in Q3 2022.","Active partner programs 314, up from 291 at year-start; added Novartis, GigaMune, Polaris as new partners.","Cash & short-term investments $96.6M at Sep 30; expects year-end cash slightly below year-end 2022.","Nine-month revenue $29.3M (up 24% YoY) from milestone payments; net loss $36.6M ($0.37/share).","Appointed Steve Love to Board (Audit Chair) and Yasmina Abdiche as VP of Exploratory Research."],"urls":{"canonical":"https://secwatch.observer/filing/0001846253-23-000117","json":"https://secwatch.observer/filing/0001846253-23-000117.json","markdown":"https://secwatch.observer/filing/0001846253-23-000117.md","text":"https://secwatch.observer/filing/0001846253-23-000117.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1846253/000184625323000117/0001846253-23-000117-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1846253/000184625323000117/oabi-20231109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T07:39:37.846578+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3e00dd817253af27bf96fcebf216f7885b1a419c","claim":"OmniAb, Inc. reported three and nine months ended September 30, 2023 results: revenue $5.5 million, net income $15.7 million, or $0.16 per share.","evidence_excerpt":"Virtual Event later today, which will include an overview of our new Omni dAb TM technology.” Third Quarter 2023 Financial Results Revenue for the third quarter of 2023 was $5.5 million, compared with $6.9 million for the same period in 2022, with the decrease primarily driven by lower service revenue as a result of the completion of discovery work on certain","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1846253/000184625323000117/0001846253-23-000117-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and nine months ended September 30, 2023"},{"label":"Revenue","value":"$5.5 million"},{"label":"Net income","value":"$15.7 million, or $0.16 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}